Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients
Purpose. Systemic mastocytosis (SM) is characterized by a clonal proliferation of neoplastic mast cells (MCs) in one or more extracutaneous organs including the bone marrow (BM). SM is often associated with osteoporosis (OP) and fractures. Hypertryptasemia usually occurs in SM. We investigated the p...
Saved in:
| Main Authors: | Giulia Carosi, Gregorio Guabello, Matteo Longhi, Federica Grifoni, Elena Passeri, Sabrina Corbetta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2020/5785378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity
by: C. Aresta, et al.
Published: (2019-01-01) -
Genetic and clinical insights into MAST4-related neurodevelopmental disorders
by: Xiaohong Zheng, et al.
Published: (2025-06-01) -
Bone marrow mast cells and mast cell tryptase in plasma cell disorders
by: Raveena Yadav, et al.
Published: (2025-03-01) -
On the Role of Mast Cells and Their Proteases in the Severe COVID-19
by: A. V. Budnevsky, et al.
Published: (2024-06-01) -
Hereditary alpha-tryptasemia and monoclonal mast cell disorders
by: Yannick Chantran, et al.
Published: (2025-06-01)